- Senda Biosciences and Laronde Unite to Pioneer the Design and Deployment of Fully Programmable Medicines to Transform Patient Care
- Guillaume Pfefer, Ph.D., MBA to serve as CEO; John Mendlein, Ph.D. to serve as Executive Chairman
Read more at prnewswire.com